Endpoints News
Another warning letter for Empower Read in browser
Endpoints News
Thursday, 24 September 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
THE BANK THAT TAKES YOU FROM SEED STAGE TO WORLD STAGE
J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most.
sponsored by J.P.Morgan
Slowing the pace
AI doomsday predictions could put the brakes on health tech innovation. 
At least one healthcare company — electronic health record giant Epic, which offers AI tools for hospitals and clinicians — has paused tech development for at least six weeks to ensure its systems are secure, Modern Healthcare reported. The move comes after rogue AI agents at OpenAI, Anthropic and elsewhere hacked systems all on their own.
Generative AI, of course, has made big inroads into healthcare over the last couple of years. Hospital systems first adopted ambient scribes, and then turned to tools for prior authorizations, coding and billing, and clinical decision support. Now the federal government is encouraging the development of AI for medical care delivery, and startups are meeting the challenge.
But as I wrote Tuesday, it’s possible the public’s growing distrust of the technology could derail that effort. Leaders of OpenAI and Anthropic seem to agree that the pace of AI development should slow down. 
Robert Wachter, professor of medicine at UCSF, wrote in his blog last week that slowing AI in healthcare would be a mistake, however. Putting the development of frontier models on ice is sensible; halting healthcare’s adoption of models already available could cost lives, he said.
“The peculiar fact about medicine is that we don’t need the frontier labs to keep pushing our frontier,” Wachter wrote. “The American healthcare system is a mess, failing to meet our needs in quality, safety, access, equity and cost. This means that the AI we already have is good enough to address many of our most important clinical problems.” 
It seems his fear might be materializing. Epic’s CEO Judy Faulkner said that going forward, the company will develop at a different pace, because of the constant need to protect against cyberattacks. 
Will others follow Epic’s lead? 
- Shelby
Here’s what’s new
Compounder Empower receives FDA warning letter over GLP-1s
The FDA has is­sued a warn­ing let­ter to com­pounder Em­pow­er Phar­ma­cy over its GLP-1 weight loss treat­ments. It’s the third warn­ing the Hous­ton-based com­pa­ny has re­ceived in less than two years.
Bridging coverage
700,000 The number of people who are on GLP-1s through Medicare coverage, according to Eli Lilly CEO David Ricks. The temporary Medicare Bridge program launched in July. 
This week in health Тech
Heidi, a startup founded in Australia that has an AI scribe and clinical decision support tools, raised $340 million. The funding is a combination of a $100 million Series C round that values the company at $900 million, as well as a $240 million growth investment led by General Catalyst’s Customer Value Fund.
Bessemer Venture Partners raised $5.75 billion. $1.75 billion is earmarked for seed and early stage investing, and $4 billion is for growth investing. Bessemer has backed startups such as Abridge and Plenful.
OpenAI expanded on HealthBench with a new benchmark for evaluating how large language models perform in mental health conversations. Called MentalHealthBench, OpenAI said the intent was to focus on examples beyond emergencies to understand how the model performs in non-emergent scenarios.

Anthropic and OpenEvidence are partnering to provide free clinical decision support to doctors in around 100 low and middle-income countries. The tool gives answers based on medical research, treatment guidelines and local healthcare data and infrastructure.

Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times